Format

Send to

Choose Destination
Clin Rheumatol. 2007 Aug;26(8):1344-5. Epub 2006 Jul 25.

Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept.

Author information

1
Department of Pulmonary Disease, Aristotle University of Thessaloniki Medical School-G. Papanikolaou Hospital, Exohi, Thessaloniki, 57010, Greece. bagalasv@yahoo.com

Abstract

Visceral leishmaniasis (VL) is a severe disease that can develop in immunocompromised patients. Antitumor necrosis factor-alpha (TNF-alpha) treatment of rheumatoid arthritis can result in clinical benefits, but with an increased risk of opportunistic infections. Leishmania infection in patients treated with TNF-alpha antagonists is extremely rare; for this reason, we report a patient with VL after etanercept treatment who had an unfavorable outcome.

PMID:
16865310
DOI:
10.1007/s10067-006-0356-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center